Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease. Revista Alergia México, [S. l.], v. 64, n. 1, p. 52–65, 2017. DOI: 10.29262/ram.v64i1.233. Disponível em: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/233. Acesso em: 24 sep. 2026.